Cantel Medical Corp (CMD.N)
CMD.N on New York Stock Exchange
84.65USD
15 Feb 2019
84.65USD
15 Feb 2019
Change (% chg)
$2.13 (+2.58%)
$2.13 (+2.58%)
Prev Close
$82.52
$82.52
Open
$83.13
$83.13
Day's High
$85.07
$85.07
Day's Low
$83.13
$83.13
Volume
87,534
87,534
Avg. Vol
52,946
52,946
52-wk High
$130.92
$130.92
52-wk Low
$69.44
$69.44
Revenue & Earnings Per Share
Revenue* | Earnings Per Share** | ||
---|---|---|---|
FY 2019 | Oct | 225.59 | 0.482 |
FY 2018 | Jul '18 | 228.85 | 0.411 |
Apr '18 | 217.27 | 0.435 | |
Jan '18 | 213.03 | 0.576 | |
Oct | 212.77 | 0.548 | |
FY 2017 | Jul '17 | 205.50 | 0.407 |
Apr '17 | 192.11 | 0.419 | |
Jan '17 | 184.82 | 0.432 | |
Oct | 187.73 | 0.450 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
# of Estimates | Mean | High | Low | 1 Year Ago | |
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Oct-19 | 2 | 248.15 | 252.90 | 243.40 | -- |
Quarter Ending Jan-19 | 4 | 226.95 | 228.80 | 225.10 | 238.11 |
Year Ending Jul-19 | 5 | 941.92 | 964.00 | 929.70 | 987.61 |
Year Ending Jul-20 | 5 | 1,030.80 | 1,081.00 | 1,000.20 | 1,103.39 |
Earnings (per share) | |||||
Quarter Ending Oct-19 | 2 | 0.67 | 0.69 | 0.65 | 0.75 |
Quarter Ending Jan-19 | 3 | 0.62 | 0.62 | 0.62 | 0.64 |
Year Ending Jul-19 | 4 | 2.63 | 2.76 | 2.58 | 2.84 |
Year Ending Jul-20 | 4 | 2.99 | 3.26 | 2.86 | 3.17 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Company | industry | sector | ||
---|---|---|---|---|
P/E Ratio (TTM) | 56.96 | 32.21 | 33.70 | |
P/E High - Last 5 Yrs. | 47.58 | 40.37 | 49.87 | |
P/E Low - Last 5 Yrs. | 27.86 | 19.61 | 24.25 | |
Beta | 1.22 | 0.79 | 0.90 | |
Price to Sales (TTM) | 5.27 | 6.69 | 6.29 | |
Price to Book (MRQ) | 7.75 | 4.95 | 5.26 | |
Price to Tangible Book (MRQ) | 46.14 | 16.59 | 6.77 | |
Price to Cash Flow (TTM) | 38.72 | 21.70 | 24.98 | |
% Owned Institutions | 86.64 | 4.68 | 1.69 |
Dividends
Company | industry | sector | ||
---|---|---|---|---|
Dividend Yield | 0.14 | 1.05 | 1.40 | |
Dividend Yield - 5 Year Avg | 0.21 | 1.26 | 1.42 | |
Dividend 5 Year Growth Rate | 15.07 | 16.24 | 4.85 | |
Payout Ratio(TTM) | 0.00 | 30.85 | 41.03 |
Growth Rates
Company | industry | sector | ||
---|---|---|---|---|
Sales (MRQ) vs Qtr. 1 Yr. Ago | 14.80 | 8.67 | 12.75 | |
Sales (TTM) vs TTM 1 Yr. Ago | 15.86 | 2.19 | 5.84 | |
Sales - 5 Yr. Growth Rate | 14.79 | 8.65 | 11.23 | |
EPS (MRQ) vs Qtr. 1 Yr. Ago | 4.19 | 59.77 | 47.15 | |
EPS (TTM) vs TTM 1 Yr. Ago | 18.87 | -- | -- | |
EPS - 5 Yr. Growth Rate | 17.32 | 19.62 | 10.85 | |
Capital Spending - 5 Yr. Growth Rate | 37.52 | 7.92 | 15.20 |
Financial Strength
Company | industry | sector | |
---|---|---|---|
Quick Ratio (MRQ) | 1.49 | 2.44 | 2.25 |
Current Ratio (MRQ) | 2.41 | 3.17 | 3.08 |
LT Debt to Equity (MRQ) | 24.05 | 29.53 | 11.38 |
Total Debt to Equity (MRQ) | 24.05 | 36.50 | 16.12 |
Interest Coverage (TTM) | 31.31 | 15.21 | 29.47 |
Profitability Ratios
Company | industry | sector | ||
---|---|---|---|---|
Gross Margin (TTM) | 47.72 | 58.80 | 53.81 | |
Gross Margin - 5 Yr. Avg. | 45.67 | 58.29 | 52.18 | |
EBITD Margin (TTM) | 19.80 | -- | -- | |
EBITD - 5 Yr. Avg | 19.23 | 22.93 | 12.87 | |
Operating Margin (TTM) | 14.34 | 17.67 | 6.20 | |
Operating Margin - 5 Yr. Avg. | 14.43 | 15.83 | 8.31 | |
Pre-Tax Margin (TTM) | 13.79 | 17.43 | 7.16 | |
Pre-Tax Margin - 5 Yr. Avg. | 13.91 | 16.09 | 8.61 | |
Net Profit Margin (TTM) | 9.27 | 13.32 | 3.30 | |
Net Profit Margin - 5 Yr. Avg. | 8.98 | 11.24 | 4.89 | |
Effective Tax Rate (TTM) | 32.81 | 23.16 | 22.91 | |
Effective Tax Rate - 5 Yr. Avg. | 35.41 | 28.89 | 23.38 |
Efficiency
Company | industry | sector | ||
---|---|---|---|---|
Revenue/Employee (TTM) | 329,549 | 28,762,491 | 842,398,385 | |
Net Income/Employee (TTM) | 30,543 | 3,194,057 | 99,842,801 | |
Receivable Turnover (TTM) | 7.55 | 5.08 | 5.71 | |
Inventory Turnover (TTM) | 4.23 | 3.28 | 3.47 | |
Asset Turnover (TTM) | 1.04 | 0.79 | 0.93 |
Management Effectiveness
Company | industry | sector | ||
---|---|---|---|---|
Return on Assets (TTM) | 9.64 | 10.47 | 11.06 | |
Return on Assets - 5 Yr. Avg. | 8.99 | 8.98 | 12.20 | |
Return on Investment (TTM) | 11.17 | 13.74 | 14.45 | |
Return on Investment - 5 Yr. Avg. | 10.31 | 11.63 | 15.87 | |
Return on Equity (TTM) | 14.50 | 16.49 | 15.96 | |
Return on Equity - 5 Yr. Avg. | 13.31 | 13.95 | 17.00 |
1 Year | 3 Year | 5 Year | |
---|---|---|---|
Sales % | 15.86 | 16.37 | 14.79 |
EPS (TTM) % | 18.87 | 17.85 | 17.32 |
Dividend % | -18.75 | 16.60 | 15.07 |
Note: Units in Millions of US Dollars
Performance for Cantel Medical Corp
Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
---|---|---|---|---|
4 Week | 18.42 | 14.33 | 99 | 52 |
13 Week | 29.19 | 22.90 | 99 | 72 |
26 Week | 31.51 | 21.52 | 99 | 63 |
52 Week | 23.17 | 4.40 | 99 | 42 |
YTD | 23.53 | 8.48 | 99 | 39 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
% Shares Owned: | 88.48% |
# of Holders: | 341 |
Total Shares Held: | 36,913,754 |
3 Mo. Net Change: | -482,915 |
# New Positions: | 30 |
# Closed Positions: | 68 |
# Increased Positions: | 135 |
# Reduced Positions: | 194 |
# Net Buyers: | -59 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.